Press Releases

SAN FRANCISCO, Nov. 22, 2019 /PRNewswire/ -- ClearUP® Sinus Pain Relief from Tivic Health™ Systems Inc. was named today to

ATLANTA, Nov. 22, 2019 /PRNewswire/ -- Intent Solutions, an Atlanta-based company that provides technology to secure medications and track prescription adherence, is collaborating with AT&T to integrate LTE-M cellular technology into the new release of Intent's tad™ dispensing system.This marks a signifi

TARRYTOWN, N.Y., Nov. 22, 2019 /PRNewswire/ --Columbia's highest honor bestowed for Yancopoulos' contributions to science and medicineRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that George D. Yancopoulos, M.D., Ph.D., Co-Founder, President and Chief Scientific Officer

SAN JOSE, Calif., Nov. 22, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against canc

WASHINGTON, Nov. 22, 2019 /PRNewswire/ -- The nation's leading hospital and healthcare experts convened in Washington, D.C., Nov. 17-19, 2019, for the seventh annual U.S. News & World Report

PRINCETON, N.J., Nov. 22, 2019 /PRNewswire/ -- Systech was chosen as winner in The Abbott Connected Health Challenge&nb

VENTURA, Calif., Nov. 22, 2019 /PRNewswire/ -- A California-based pet wellness company has launched a new natural health supplement formulated to boost your pet's immune system and protect dogs and cats against cancer and other life-threatening diseases."Cancer is the number-one killer of dogs and cats," explains VetSmart Formulas founder and CEO,

MOUNTAIN VIEW, Calif., Nov. 22, 2019 /PRNewswire/ -- If there is one thing a majority of Americans can agree on, it's that healthcare costs are too expensive and they want upfront pricing. H

CALGARY, Nov. 21, 2019 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (CSE: WLLW, OTCQB: CANSF) has released its financial and operating results for the three and nine months ended September 30, 2019. "Over the past few months, Willow has continued to advance its business strateg

MORRISVILLE, N.C., Nov. 21, 2019 /PRNewswire/ -- Three years in the market, the spencer® Direct-to-Patient platform is consistently demonstrating a new standard of greater than 95% adherence among chronically-ill patients. Adherence for some individuals managing on average seven medications daily has reached 97% this year.